First Header Logo Second Header Logo

Connection

Karl-Erik Andersson to Urinary Bladder, Overactive

Back to Details
This is a "connection" page, showing publications Karl-Erik Andersson has written about Urinary Bladder, Overactive.
Karl-Erik Andersson
Connection Strength
11.300
Urinary Bladder, Overactive
  1. Andersson KE. Re: Nonantimuscarinic Treatment for Overactive Bladder: A Systematic Review. Eur Urol. 2016 12; 70(6):1077.
    View in: PubMed
    Score: 0.465
  2. Andersson KE. Potential Future Pharmacological Treatment of Bladder Dysfunction. Basic Clin Pharmacol Toxicol. 2016 Oct; 119 Suppl 3:75-85.
    View in: PubMed
    Score: 0.452
  3. Andersson KE. Pharmacology: On the mode of action of mirabegron. Nat Rev Urol. 2016 Mar; 13(3):131-2.
    View in: PubMed
    Score: 0.443
  4. Andersson KE. Drug therapy of overactive bladder--what is coming next? Korean J Urol. 2015 Oct; 56(10):673-9.
    View in: PubMed
    Score: 0.437
  5. Andersson KE. The use of pharmacotherapy for male patients with urgency and stress incontinence. Curr Opin Urol. 2014 Nov; 24(6):571-7.
    View in: PubMed
    Score: 0.410
  6. Andersson KE. Potential of stem cell treatment in detrusor dysfunction. Adv Drug Deliv Rev. 2015 Mar; 82-83:117-22.
    View in: PubMed
    Score: 0.409
  7. Yamagishi T, Ishizuka O, Imamura T, Yokoyama H, Ogawa T, Kurizaki Y, Nishizawa O, Andersson KE. Alpha1 -adrenergic receptors mediate bladder overactivity induced by cold stress in rats with bladder outlet obstruction. Neurourol Urodyn. 2015 Mar; 34(3):280-5.
    View in: PubMed
    Score: 0.386
  8. Andersson KE. ß3-receptor agonists for overactive bladder--new frontier or more of the same? Curr Urol Rep. 2013 Oct; 14(5):435-41.
    View in: PubMed
    Score: 0.380
  9. Sawada N, Nomiya M, Hood B, Koslov D, Zarifpour M, Andersson KE. Protective effect of a ß3-adrenoceptor agonist on bladder function in a rat model of chronic bladder ischemia. Eur Urol. 2013 Oct; 64(4):664-71.
    View in: PubMed
    Score: 0.374
  10. Andersson KE, Martin N, Nitti V. Selective ß3-adrenoceptor agonists for the treatment of overactive bladder. J Urol. 2013 Oct; 190(4):1173-80.
    View in: PubMed
    Score: 0.365
  11. Hood B, Andersson KE. Common theme for drugs effective in overactive bladder treatment: inhibition of afferent signaling from the bladder. Int J Urol. 2013 Jan; 20(1):21-7.
    View in: PubMed
    Score: 0.356
  12. Noguchi W, Ishizuka O, Imamura T, Kurizaki Y, Yamagishi T, Yokoyama H, Lei Z, Silwal SG, Nishizawa O, Andersson KE. The relationship between a1-adrenergic receptors and TRPM8 channels in detrusor overactivity induced by cold stress in ovariectomized rats. J Urol. 2013 May; 189(5):1975-81.
    View in: PubMed
    Score: 0.355
  13. Lei Z, Ishizuka O, Imamura T, Noguchi W, Yamagishi T, Yokoyama H, Kurizaki Y, Sudha GS, Hosoda T, Nishizawa O, Andersson KE. Functional roles of transient receptor potential melastatin 8 (TRPM8) channels in the cold stress-induced detrusor overactivity pathways in conscious rats. Neurourol Urodyn. 2013 Jun; 32(5):500-4.
    View in: PubMed
    Score: 0.354
  14. Kanai A, Zabbarova I, Oefelein M, Radziszewski P, Ikeda Y, Andersson KE. Mechanisms of action of botulinum neurotoxins, ß3-adrenergic receptor agonists, and PDE5 inhibitors in modulating detrusor function in overactive bladders: ICI-RS 2011. Neurourol Urodyn. 2012 Mar; 31(3):300-8.
    View in: PubMed
    Score: 0.338
  15. Andersson KE, Campeau L, Olshansky B. Cardiac effects of muscarinic receptor antagonists used for voiding dysfunction. Br J Clin Pharmacol. 2011 Aug; 72(2):186-96.
    View in: PubMed
    Score: 0.327
  16. Asche CV, Kim J, Kulkarni AS, Chakravarti P, Andersson KE. Presence of central nervous system, cardiovascular and overall co-morbidity burden in patients with overactive bladder disorder in a real-world setting. BJU Int. 2012 Feb; 109(4):572-80.
    View in: PubMed
    Score: 0.326
  17. Andersson KE. Antimuscarinic mechanisms and the overactive detrusor: an update. Eur Urol. 2011 Mar; 59(3):377-86.
    View in: PubMed
    Score: 0.313
  18. Andersson KE, Gratzke C, Hedlund P. The role of the transient receptor potential (TRP) superfamily of cation-selective channels in the management of the overactive bladder. BJU Int. 2010 Oct; 106(8):1114-27.
    View in: PubMed
    Score: 0.309
  19. Andersson KE. Detrusor myocyte activity and afferent signaling. Neurourol Urodyn. 2010; 29(1):97-106.
    View in: PubMed
    Score: 0.293
  20. Andersson KE, Sarawate C, Kahler KH, Stanley EL, Kulkarni AS. Cardiovascular morbidity, heart rates and use of antimuscarinics in patients with overactive bladder. BJU Int. 2010 Jul; 106(2):268-74.
    View in: PubMed
    Score: 0.291
  21. Andersson KE. Pharmacotherapy of the overactive bladder. Discov Med. 2009 Oct; 8(42):118-24.
    View in: PubMed
    Score: 0.288
  22. Andersson KE. Prostanoid receptor subtypes: new targets for OAB drugs? J Urol. 2009 Nov; 182(5):2099-100.
    View in: PubMed
    Score: 0.287
  23. Andersson KE, Chapple CR, Cardozo L, Cruz F, Hashim H, Michel MC, Tannenbaum C, Wein AJ. Pharmacological treatment of overactive bladder: report from the International Consultation on Incontinence. Curr Opin Urol. 2009 Jul; 19(4):380-94.
    View in: PubMed
    Score: 0.283
  24. Chen Z, Ishizuka O, Imamura T, Aizawa N, Igawa Y, Nishizawa O, Andersson KE. Role of alpha1-adrenergic receptors in detrusor overactivity induced by cold stress in conscious rats. Neurourol Urodyn. 2009; 28(3):251-6.
    View in: PubMed
    Score: 0.274
  25. Imamura T, Ishizuka O, Zhong C, Ogawa T, Nakayama T, Kurizaki Y, Tanabe T, Nishizawa O, Andersson KE. An extract (THC-002) of Ba-Wei-Die-Huang-Wan inhibits expression of tachykinins, and P2X3 and TRPV1 receptors, and inhibits ATP-induced detrusor overactivity in spontaneously hypertensive rats. Neurourol Urodyn. 2009; 28(6):529-34.
    View in: PubMed
    Score: 0.274
  26. Andersson KE, Fullhase C, Soler R. Urothelial effects of oral agents for overactive bladder. Curr Urol Rep. 2008 Nov; 9(6):459-64.
    View in: PubMed
    Score: 0.270
  27. Ney P, Pandita RK, Newgreen DT, Breidenbach A, Stöhr T, Andersson KE. Pharmacological characterization of a novel investigational antimuscarinic drug, fesoterodine, in vitro and in vivo. BJU Int. 2008 Apr; 101(8):1036-42.
    View in: PubMed
    Score: 0.257
  28. Abrams P, Andersson KE. Muscarinic receptor antagonists for overactive bladder. BJU Int. 2007 Nov; 100(5):987-1006.
    View in: PubMed
    Score: 0.252
  29. Andersson KE, Olshansky B. Treating patients with overactive bladder syndrome with antimuscarinics: heart rate considerations. BJU Int. 2007 Nov; 100(5):1007-14.
    View in: PubMed
    Score: 0.252
  30. Kallner HK, Elmér C, Andersson KE, Altman D. Hormonal influence on the effect of mirabegron treatment for overactive bladder. Menopause. 2016 12; 23(12):1303-1306.
    View in: PubMed
    Score: 0.118
  31. Kirschner-Hermanns R, Anding R, Rosier P, Birder L, Andersson KE, Djurhuus JC. Fundamentals and clinical perspective of urethral sphincter instability as a contributing factor in patients with lower urinary tract dysfunction--ICI-RS 2014. Neurourol Urodyn. 2016 Feb; 35(2):318-23.
    View in: PubMed
    Score: 0.112
  32. Andersson KE, Nomiya M, Yamaguchi O. Chronic Pelvic Ischemia: Contribution to the Pathogenesis of Lower Urinary Tract Symptoms (LUTS): A New Target for Pharmacological Treatment? Low Urin Tract Symptoms. 2015 Jan; 7(1):1-8.
    View in: PubMed
    Score: 0.103
  33. Birder LA, Andersson KE, Kanai AJ, Hanna-Mitchell AT, Fry CH. Urothelial mucosal signaling and the overactive bladder-ICI-RS 2013. Neurourol Urodyn. 2014 Jun; 33(5):597-601.
    View in: PubMed
    Score: 0.099
  34. Füllhase C, Hennenberg M, Giese A, Schmidt M, Strittmatter F, Soler R, Gratzke C, Andersson KE, Stief C. Presence of phosphodiesterase type 5 in the spinal cord and its involvement in bladder outflow obstruction related bladder overactivity. J Urol. 2013 Oct; 190(4):1430-5.
    View in: PubMed
    Score: 0.092
  35. Svalø J, Nordling J, Bouchelouche K, Andersson KE, Korstanje C, Bouchelouche P. The novel ß3-adrenoceptor agonist mirabegron reduces carbachol-induced contractile activity in detrusor tissue from patients with bladder outflow obstruction with or without detrusor overactivity. Eur J Pharmacol. 2013 Jan 15; 699(1-3):101-5.
    View in: PubMed
    Score: 0.090
  36. Füllhase C, Russo A, Castiglione F, Benigni F, Campeau L, Montorsi F, Gratzke C, Bettiga A, Stief C, Andersson KE, Hedlund P. Spinal cord FAAH in normal micturition control and bladder overactivity in awake rats. J Urol. 2013 Jun; 189(6):2364-70.
    View in: PubMed
    Score: 0.090
  37. Li K, Yao J, Sawada N, Kitamura M, Andersson KE, Takeda M. ß-Catenin signaling contributes to platelet derived growth factor elicited bladder smooth muscle cell contraction through up-regulation of Cx43 expression. J Urol. 2012 Jul; 188(1):307-15.
    View in: PubMed
    Score: 0.086
  38. Nomiya M, Sagawa K, Yazaki J, Takahashi N, Kushida N, Haga N, Aikawa K, Matsui T, Oka M, Fukui T, Andersson KE, Yamaguchi O. Increased bladder activity is associated with elevated oxidative stress markers and proinflammatory cytokines in a rat model of atherosclerosis-induced chronic bladder ischemia. Neurourol Urodyn. 2012 Jan; 31(1):185-9.
    View in: PubMed
    Score: 0.083
  39. Jin LH, Andersson KE, Han JU, Kwon YH, Park CS, Shin HY, Yoon SM, Lee T. Persistent detrusor overactivity in rats after relief of partial urethral obstruction. . 2011 Oct; 301(4):R896-904.
    View in: PubMed
    Score: 0.082
  40. Kanai A, Wyndaele JJ, Andersson KE, Fry C, Ikeda Y, Zabbarova I, De Wachter S. Researching bladder afferents-determining the effects of ß(3) -adrenergic receptor agonists and botulinum toxin type-A. Neurourol Urodyn. 2011 Jun; 30(5):684-91.
    View in: PubMed
    Score: 0.081
  41. Russo A, Castiglione F, Salonia A, Benigni F, Rigatti P, Montorsi F, Andersson KE, Hedlund P. Effects of the gonadotropin-releasing hormone antagonist ganirelix on normal micturition and prostaglandin E(2)-induced detrusor overactivity in conscious female rats. Eur Urol. 2011 May; 59(5):868-74.
    View in: PubMed
    Score: 0.078
  42. Kurizaki Y, Ishizuka O, Imamura T, Ichino M, Ogawa T, Igawa Y, Nishizawa O, Andersson KE. Relation between expression of a(1)-adrenoceptor mRNAs in bladder mucosa and urodynamic findings in men with lower urinary tract symptoms. Scand J Urol Nephrol. 2011 Feb; 45(1):15-9.
    View in: PubMed
    Score: 0.077
  43. Jin LH, Andersson KE, Kwon YH, Yoon SM, Lee T. Selection of a control rat for conscious spontaneous hypertensive rats in studies of detrusor overactivity on the basis of measurement of intra-abdominal pressures. Neurourol Urodyn. 2010 Sep; 29(7):1338-43.
    View in: PubMed
    Score: 0.077
  44. Roosen A, Chapple CR, Dmochowski RR, Fowler CJ, Gratzke C, Roehrborn CG, Stief CG, Andersson KE. A refocus on the bladder as the originator of storage lower urinary tract symptoms: a systematic review of the latest literature. Eur Urol. 2009 Nov; 56(5):810-9.
    View in: PubMed
    Score: 0.071
  45. Jin LH, Andersson KE, Kwon YH, Park CS, Yoon SM, Lee T. Substantial detrusor overactivity in conscious spontaneously hypertensive rats with hyperactive behaviour. Scand J Urol Nephrol. 2009; 43(1):3-7.
    View in: PubMed
    Score: 0.068
  46. Abrams P, Andersson KE, Buccafusco JJ, Chapple C, de Groat WC, Fryer AD, Kay G, Laties A, Nathanson NM, Pasricha PJ, Wein AJ. Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder. Br J Pharmacol. 2006 Jul; 148(5):565-78.
    View in: PubMed
    Score: 0.057
  47. Lee T, Andersson KE, Streng T, Hedlund P. Simultaneous registration of intraabdominal and intravesical pressures during cystometry in conscious rats--effects of bladder outlet obstruction and intravesical PGE2. Neurourol Urodyn. 2008; 27(1):88-95.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.